27 This might have been due to the fact that even within Tanzania, this proportion varies by location, as it was as low as 2.0% in the northern zone and as high as 8.6% in the southern zone of the country. 2 This observation is fairly similar to the prevalence observed in Lesotho, where MSP among women in the last 12 months is 6% according to the Lesotho Demographic and Health Survey.
Within one year, this proportion was still high for AMI (58.1%) and stroke (73.5%), but considerably lower for the hip fracture patients (37.9%).
Then, we examined this proportion within this age range according to period, sex, and race/ethnic group and found that the proportion did not vary meaningfully by these characteristics, although it was slightly lower among Blacks (89.8%) and Asians/Pacific Islanders (89.9%) than among other race/ethnic groups (Table 1).
Assuming that a proportion of 50% would respond positively to a question on long-term follow-up, with 400 responders to the survey, we would be able to estimate this proportion within ±5%, that is, 95% confidence interval from 45 to 55% (Altman et al, 2000).
This may be explained by the fact that isomaltulose and sucrose, respectively, constituted only approximately 10% of total caloric intake resulting in an approximate reduction of the overall GI by ∼6 units according to a simple calculation (3), and it is obvious that this proportion within a mixed diet is too small to evoke distinct effects on metabolic control.
Among high track students with at least a year of dual training, around 30% of them accumulate 3 years within the same occupation, while this proportion is slightly lower among low track students (24%).
This proportion lies within the range of functional sites observed for transcription factors (Cusanovich et al., 2014).
This proportion is within the 1-10% range of potential targets that have been reported to be regulated by other transcription factors [ 44- 46].
This proportion is within the limits of what could appear by coincidence from a normal distribution (24%), and with a mean learning outcome of 0.7 (0.7).
In all, 11.5% of colon and 5.4% of rectal cancer patients died within a month of diagnosis: this proportion decreased significantly over the study period.
